BIO|CONCEPT.BIOMONITOR III

Launched by BIOTRONIK SE & CO. KG · Feb 20, 2019

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patient is at high risk of developing a clinically important cardiac arrhythmia; or Patient is undergoing investigation for symptoms such as palpitations, pre-syncope or syncope, that are suggestive of an underlying cardiac arrhythmia; or Patient is undergoing investigation for the detection of atrial fibrillation following cryptogenic stroke; or Patient is planned for AF ablative procedure or has already undergone an AF ablative procedure.
• • Patient is able to understand the nature of study and has provided written informed consent.
• • Patient is willing and able to perform all follow up visits at the study site.
• • Patient is willing and able to use the CardioMessenger and accepts the BIOTRONIK Home Monitoring concept.
• Exclusion Criteria:
• • Patients implanted with ICD or pacemaker.
• • Patient is pregnant or breast feeding.
• • Patient is less than 18 years old.
• • Patient is participating in another interventional clinical investigation
• • Patient´s life-expectancy is less than 6 months.